We are live on
!
Find out more
Qube Research & Technologies (QRT) Portfolio holdings
AUM
$89.9B
1-Year Est. Return
20.22%
This Fund
S&P 500
This Quarter
Est. Return
-6.27%
1 Year Est. Return
+20.22%
3 Year Est. Return
+42.42%
5 Year Est. Return
+23.97%
10 Year Est. Return
–
AUM
$16.8B
AUM Growth
+$3.24B
(+24%)
Cap. Flow
+$4.87B
Cap. Flow
% of AUM
28.99%
Top 10 Holdings %
Top 10 Hldgs %
10.37%
Holding
3,295
New
862
Increased
762
Reduced
768
Closed
837
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Visa
V
|
+$169M |
| 2 |
Coca-Cola
KO
|
+$155M |
| 3 |
McDonald's
MCD
|
+$140M |
| 4 |
Mondelez International
MDLZ
|
+$127M |
| 5 |
DRE
Duke Realty Corp.
DRE
|
+$120M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Marathon Petroleum
MPC
|
+$174M |
| 2 |
Berkshire Hathaway Class B
BRK.B
|
+$133M |
| 3 |
Workday
WDAY
|
+$110M |
| 4 |
Johnson & Johnson
JNJ
|
+$98.4M |
| 5 |
ConocoPhillips
COP
|
+$93.4M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 20.63% |
| 2 | Financials | 11.8% |
| 3 | Healthcare | 10.7% |
| 4 | Industrials | 9.22% |
| 5 | Consumer Discretionary | 8.7% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1426
Pliant Therapeutics
PLRX
$66.3M
| $562K | ﹤0.01% |
26,901
+13,442
| +100% | +$257K |
|
1427
Invesco S&P 500 Pure Growth ETF
RPG
$1.97B
| $558K | ﹤0.01% |
19,315
+13,380
| +225% | +$428K |
|
|
ITOS
1428
DELISTED
iTeos Therapeutics
ITOS
| $557K | ﹤0.01% |
+29,242
| New | +$674K |
|
1429
Guidewire Software
GWRE
$13.3B
| $556K | ﹤0.01% |
+9,026
| New | +$652K |
|
1430
Teradata
TDC
$2.75B
| $556K | ﹤0.01% |
17,889
-20,449
| -53% | -$715K |
|
1431
Alto Ingredients
ALTO
$345M
| $552K | ﹤0.01% |
+151,606
| New | +$638K |
|
|
HEES
1432
DELISTED
H&E Equipment Services
HEES
| $552K | ﹤0.01% |
19,482
+8,374
| +75% | +$263K |
|
1433
Plexus
PLXS
$6.69B
| $552K | ﹤0.01% |
+6,300
| New | +$562K |
|
|
SCLE
1434
DELISTED
Broadscale Acquisition Corp. Class A common stock
SCLE
| $552K | ﹤0.01% |
56,091
-192,491
| -77% | -$1.9M |
|
1435
ARK Web x.0 ETF
ARKW
$1.64B
| $550K | ﹤0.01% |
12,042
-136,743
| -92% | -$7.4M |
|
1436
ProShares S&P 500 Dividend Aristocrats ETF
NOBL
$11.9B
| $542K | ﹤0.01% |
+13,564
| New | +$600K |
|
1437
Banco Santander
SAN
$200B
| $540K | ﹤0.01% |
+232,744
| New | +$582K |
|
1438
CorVel
CRVL
$3.14B
| $539K | ﹤0.01% |
+11,682
| New | +$606K |
|
1439
RELX
RELX
$66B
| $538K | ﹤0.01% |
+22,119
| New | +$601K |
|
1440
InMode
INMD
$889M
| $536K | ﹤0.01% |
18,426
-201
| -1% | -$6.23K |
|
1441
First Trust NASDAQ-100 Technology Index Fund
QTEC
$4.41B
| $536K | ﹤0.01% |
5,107
-10,284
| -67% | -$1.25M |
|
1442
SITE Centers
SITC
$235M
| $535K | ﹤0.01% |
+64,014
| New | +$670K |
|
1443
Nutanix
NTNX
$16B
| $534K | ﹤0.01% |
+25,654
| New | +$468K |
|
1444
Alkermes
ALKS
$8.42B
| $532K | ﹤0.01% |
23,834
-120,965
| -84% | -$3.15M |
|
1445
BlackRock Health Sciences Trust II
BMEZ
$968M
| $528K | ﹤0.01% |
35,354
| – | – |
|
|
THRD
1446
DELISTED
Third Harmonic Bio
THRD
| $527K | ﹤0.01% |
+27,800
| New | +$501K |
|
|
TPIC
1447
DELISTED
TPI Composites
TPIC
| $526K | ﹤0.01% |
+46,660
| New | +$738K |
|
1448
Eagle Bancorp
EGBN
$866M
| $524K | ﹤0.01% |
11,682
-32,817
| -74% | -$1.57M |
|
1449
S&T Bancorp
STBA
$1.92B
| $522K | ﹤0.01% |
+17,811
| New | +$535K |
|
1450
Flex
FLEX
$41.5B
| $521K | ﹤0.01% |
41,486
+10,047
| +32% | +$128K |
|
Similar funds
Qube Research & Technologies (QRT)'s Q3 2022 Portfolio in Review
As of Q3 2022, Qube Research & Technologies (QRT) held 3,295 positions worth $16.8B, up 24% from $13.6B the previous quarter. Its ten largest holdings account for 10% of the portfolio.
Qube Research & Technologies (QRT) deployed $4.87B of net new capital in Q3 2022, opening 862 new positions and adding to 762 existing holdings. Its largest new stake was Coca-Cola: 2,493,071 shares worth $140M.
By sector, the portfolio is most concentrated in Technology at 21% of assets, up from 19% a quarter earlier, followed by Financials and Healthcare.
On the sell side, the largest reduction was Marathon Petroleum, an estimated $174M trimmed.
- Qube Research & Technologies (QRT)'s largest Q3 2022 buy was Coca-Cola: 2,493,071 shares worth $140M.
- Qube Research & Technologies (QRT) added most to Visa in Q3 2022, an estimated $169M increase.
- Qube Research & Technologies (QRT)'s biggest Q3 2022 reduction was Marathon Petroleum, cutting an estimated $174M.
- Qube Research & Technologies (QRT) fully exited Phillips 66 in Q3 2022, selling an estimated $86.2M.
- Qube Research & Technologies (QRT)'s ten largest holdings make up 10% of its $16.8B portfolio in Q3 2022.
- Qube Research & Technologies (QRT) opened 862 new positions and closed 837 in Q3 2022.
- Qube Research & Technologies (QRT)'s portfolio value rose 24% quarter-over-quarter to $16.8B.
Based on Qube Research & Technologies (QRT)'s 13F filing for Q3 2022, filed 14 Nov 2022.